Myoprin 100 mg Tablets
PDF Leaflet Revision Date: 09 June 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Inhibition of platelet aggregation to reduce cardiovascular risks.
Dosage (summary)
100 mg to 300 mg daily, preferably at the same time.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated after 20 weeks gestation; not recommended during breastfeeding.
Key Drug Interactions
- Methotrexate
- Ibuprofen
- Anticoagulants
- SSRIs
- Alcohol
Contraindications
- Hypersensitivity to aspirin
- Uncontrolled heart failure
- Active gastrointestinal bleeding
- Severe renal impairment
- Severe hepatic impairment
Common side effects
- Nausea
- Gastrointestinal bleeding
- Dizziness
- Asthma exacerbation
Counselling Points
- Take with food to reduce gastrointestinal upset
- Do not exceed recommended dose
- Report any signs of bleeding or allergic reactions immediately
Serious warnings
- Risk of gastrointestinal ulceration
- Serious skin reactions
- Reye's syndrome in children
Important Disclaimer
The Myoprin 100 mg Tablets professional information leaflet below is the property of Ipharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
